findmyKOL

Jaehyuk Choi, MD, PhD

Basic profile

Dermatology

ORCID↗NPI↗
✓ Full record
RegionChicago, IL · MidwestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: NationalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding2015–2025Why? →

Jaehyuk Choi is a Dermatology physician. OpenAlex indexes 139 publications with 4,875 citations (h-index 36). By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
139publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,875citations

Total citations across indexed works.

36h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2015–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

676 N Saint Clair St
Suite 1600
Chicago, IL 606112927

Telephone

312-695-8106

Registry record last updated 24 Aug 2015.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    41.8%
    JAK inhibitor18.8%
    Rinvoq56%Xeljanz Xr44%
    Part D<11 patients
    Retinoid12.4%
    Bexarotene100%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    17.6%
    Gabapentinoids17.6%
    Gabapentin100%
    Part D<11 patients
  • Sensory organs

    16.5%
    Corticosteroid16.5%
    Clobetasol Propionate100%
    Part D≥17 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 2015–2025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”